GSK, a science-led global healthcare company has published its 2018 Annual Report.
According to the CEO, "In 2018 we delivered improved operating performance, started to strengthen our Pharmaceuticals pipeline, particularly in oncology, and undertook several significant transactions to support our strategy and reshape the Group's portfolio." says Emma Walmsley
We are a science-led global healthcare company. Our purpose is to help people do more, feel better, live longer.
We have three global businesses that discover, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
Read more and find out about the progress we’ve made on our long-term priorities of Innovation, Performance and Trust: https://gsk.to/2TJdZOt
We have three global businesses that discover, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
Read more and find out about the progress we’ve made on our long-term priorities of Innovation, Performance and Trust: https://gsk.to/2TJdZOt
No comments:
Post a Comment